Browse

Visceral Obesity and Insulin Resistance as Risk Factors for Colorectal Adenoma: A Cross-Sectional, Case-Control Study

DC Field Value Language
dc.contributor.authorKang, Hyoun Woo-
dc.contributor.authorKim, Donghee-
dc.contributor.authorKim, Hwa Jung-
dc.contributor.authorKim, Chung Hyeon-
dc.contributor.authorPark, Min Jung-
dc.contributor.authorCho, Sang-Heon-
dc.contributor.authorJung, Hyun Chae-
dc.contributor.authorSong, In Sung-
dc.contributor.authorLee, Hyo-Suk-
dc.contributor.authorSung, Myung-Whun-
dc.contributor.authorKim, Joo Sung-
dc.contributor.authorKim, Young Sun-
dc.date.accessioned2012-05-29T06:47:25Z-
dc.date.available2012-05-29T06:47:25Z-
dc.date.issued2010-01-
dc.identifier.citationAMERICAN JOURNAL OF GASTROENTEROLOGY; Vol.105 1; 178-187ko_KR
dc.identifier.issn0002-9270-
dc.identifier.urihttps://hdl.handle.net/10371/76558-
dc.description.abstractOBJECTIVES: Colorectal adenoma is known to be associated with obesity, but the association between colorectal adenoma and visceral adipose tissue (VAT) area measured by abdominal computed tomography (CT) has not been documented clearly. In addition, the relationship between insulin resistance and colorectal adenomas, which underlies the mechanism that links obesity and colorectal adenoma, has not been studied extensively. The aim of this study was to examine VAT area and insulin resistance as risk factors of colorectal adenoma. METHODS: A cross-sectional, case-control study was conducted in Koreans that presented for health check-ups. Subjects underwent various laboratory tests, abdominal CT, and colonoscopy. VAT, subcutaneous adipose tissue (SAT), and homeostatic metabolic assessment (HOMA) index were evaluated as potential risk factors of colorectal adenoma in 2,244 age- and sex-matched subjects. RESULTS: According to univariate analysis, the prevalences of smoking, hypertension, metabolic syndrome, and family history of colorectal cancer were higher in the adenoma group than in the normal control group. In addition, body mass index, waist circumference, triglyceride, high-density lipoprotein cholesterol, and VAT and SAT areas were significantly different in the two groups. According to the multivariate analysis adjusted for multiple confounders, VAT area was independently associated with the risk of colorectal adenoma (odds ratio (OR) = 3.09, 95 % confidence interval (CI): 2.19-4.36, highest quintile vs. lowest quintile). Mean HOMA index was higher in the adenoma group than in the control group (OR = 1.99, 95 % CI: 1.35-2.92, highest vs. lowest quintile). CONCLUSIONS: Visceral obesity was found to be an independent risk factor of colorectal adenoma, and insulin resistance was associated with the presence of colorectal adenoma. Am J Gastroenterol 2010; 105: 178-187; doi:10.1038/ajg.2009.541; published online 15 September 2009ko_KR
dc.language.isoenko_KR
dc.publisherNATURE PUBLISHING GROUPko_KR
dc.titleVisceral Obesity and Insulin Resistance as Risk Factors for Colorectal Adenoma: A Cross-Sectional, Case-Control Studyko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor강현우-
dc.contributor.AlternativeAuthor김동희-
dc.contributor.AlternativeAuthor김화정-
dc.contributor.AlternativeAuthor김정현-
dc.contributor.AlternativeAuthor김영순-
dc.contributor.AlternativeAuthor박민정-
dc.contributor.AlternativeAuthor김주성-
dc.contributor.AlternativeAuthor조상헌-
dc.contributor.AlternativeAuthor성명훈-
dc.contributor.AlternativeAuthor정현채-
dc.contributor.AlternativeAuthor이효석-
dc.contributor.AlternativeAuthor송인성-
dc.identifier.doi10.1038/ajg.2009.541-
dc.citation.journaltitleAMERICAN JOURNAL OF GASTROENTEROLOGY-
dc.description.citedreferenceChung SJ, 2008, GUT, V57, P1360, DOI 10.1136/gut.2007.147090-
dc.description.citedreferenceMillan MS, 2008, DIS COLON RECTUM, V51, P1217, DOI 10.1007/s10350-008-9315-3-
dc.description.citedreferenceOh TH, 2008, J GASTROEN HEPATOL, V23, P411, DOI 10.1111/j.1440-1746.2007.05125.x-
dc.description.citedreferenceMoghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708-
dc.description.citedreferenceGiovannucci E, 2007, AM J CLIN NUTR, V86, p836S-
dc.description.citedreferenceKim JH, 2007, CANCER EPIDEM BIOMAR, V16, P1543, DOI 10.1158/1055-9965-
dc.description.citedreferenceByeon JS, 2007, GASTROINTEST ENDOSC, V65, P1015, DOI 10.1016/j.gie.2006.12.065-
dc.description.citedreferenceWatanabe S, 2007, J GASTROENTEROL, V42, P267, DOI 10.1007/s00535-007-2033-0-
dc.description.citedreferenceAnderson JC, 2007, J CLIN GASTROENTEROL, V41, P285, DOI 10.1097/01.mcg.0000247988.96838.60-
dc.description.citedreferenceGIOVANNUCCI E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050-
dc.description.citedreferenceHowe HL, 2006, CANCER, V107, P1711, DOI 10.1002/cncr.22193-
dc.description.citedreferenceYoshida I, 2006, CLIN GASTROENTEROL H, V4, P1225, DOI 10.1016/j.cgh.2006.07.002-
dc.description.citedreferenceJohnson KT, 2006, ACAD RADIOL, V13, P963, DOI 10.1016/j.acra.2006.04.008-
dc.description.citedreferencePischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246-
dc.description.citedreferenceJohn BJ, 2006, ALIMENT PHARM THERAP, V23, P1511, DOI 10.1111/j.1365-2036.2006.02915.x-
dc.description.citedreferenceTabuchi M, 2006, WORLD J GASTROENTERO, V12, P1261-
dc.description.citedreferenceFrezza EE, 2006, GUT, V55, P285, DOI 10.1136/gut.2005.073163-
dc.description.citedreferenceSoon MS, 2005, AM J GASTROENTEROL, V100, P2749, DOI 10.1111/j.1572-0241.2005.00355.x-
dc.description.citedreferenceEdwards BK, 2005, J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289-
dc.description.citedreferenceWang YY, 2005, J GASTROEN HEPATOL, V20, P1410, DOI 10.1111/j.1440-1746.2005.03971.x-
dc.description.citedreferenceSchoen RE, 2005, GASTROENTEROLOGY, V129, P464, DOI 10.1053/j.gastro.2005.05.051-
dc.description.citedreferenceOtake S, 2005, CLIN CANCER RES, V11, P3642-
dc.description.citedreferenceKabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004-
dc.description.citedreferenceRaz I, 2005, DIABETES-METAB RES, V21, P3, DOI 10.1002/dmrr.493-
dc.description.citedreferenceMORITA T, 2005, ASIAN PAC J CANCER P, V6, P485-
dc.description.citedreferenceLimburg PJ, 2005, CANCER EPIDEM BIOMAR, V14, P133-
dc.description.citedreferenceLin J, 2004, CANCER CAUSE CONTROL, V15, P581, DOI 10.1023/B:CACO.0000036168.23351.f1-
dc.description.citedreferenceSass DA, 2004, AM J GASTROENTEROL, V99, P687, DOI 10.1111/j.1572-0241.2004.04136.x-
dc.description.citedreferenceMoore LL, 2004, INT J OBESITY, V28, P559, DOI 10.1038/sj.ijo.0802606-
dc.description.citedreferenceLieberman DA, 2003, JAMA-J AM MED ASSOC, V290, P2959, DOI 10.1001/jama.290.22.2959-
dc.description.citedreferenceSeril DN, 2003, CARCINOGENESIS, V24, P353-
dc.description.citedreferenceGoodpaster BH, 2002, CURR OPIN CLIN NUTR, V5, P481, DOI 10.1097/00075197-200209000-00005-
dc.description.citedreferenceTerry PD, 2002, GUT, V51, P191, DOI 10.1136/gut.51.2.191-
dc.description.citedreferenceCleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486-
dc.description.citedreferenceKaaks R, 2001, P NUTR SOC, V60, P91-
dc.description.citedreferenceBergman RN, 2001, J INVEST MED, V49, P119-
dc.description.citedreferencePark SK, 2000, J KOREAN MED SCI, V15, P690-
dc.description.citedreference*WHO IASO IOTF, 2000, AS PAC PERSP RED OB, P19-
dc.description.citedreference*WHO, 1999, RED MAT MORT, P9-
dc.description.citedreferenceAlberti KGMM, 1998, DIABETIC MED, V15, P539-
dc.description.citedreferenceBird CL, 1998, AM J EPIDEMIOL, V147, P670-
dc.description.citedreferenceMartinez ME, 1997, J NATL CANCER I, V89, P948-
dc.description.citedreferenceGiovannucci E, 1996, CANCER CAUSE CONTROL, V7, P253-
dc.description.citedreferenceGIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327-
dc.description.citedreferenceSHINCHI K, 1994, JPN J CANCER RES, V85, P479-
dc.description.citedreferenceWINAWER SJ, 1993, NEW ENGL J MED, V329, P1977-
dc.description.citedreferenceBOND JH, 1993, ANN INTERN MED, V119, P836-
dc.description.citedreferenceBJORK J, 1993, SCAND J GASTROENTERO, V28, P879-
dc.description.citedreferenceBAYERDORFFER E, 1993, ANN INTERN MED, V118, P481-
dc.description.citedreferenceSUADICANI P, 1993, SCAND J GASTROENTERO, V28, P285-
dc.description.citedreferenceBAYERDORFFER E, 1993, GASTROENTEROLOGY, V104, P137-
dc.description.citedreferenceTHUN MJ, 1992, J NATL CANCER I, V84, P1491-
dc.description.citedreferenceAARONSON SA, 1991, SCIENCE, V254, P1146-
dc.description.citedreferenceLEE IM, 1991, J NATL CANCER I, V83, P1324-
dc.description.citedreferenceEDDY DM, 1990, ANN INTERN MED, V113, P373-
dc.description.citedreferenceWATKINS LF, 1990, INT J CANCER, V45, P372-
dc.description.citedreferenceVOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525-
dc.description.citedreferenceMATTHEWS DR, 1985, DIABETOLOGIA, V28, P412-
dc.description.citedreferenceTOKUNAGA K, 1983, INT J OBESITY, V7, P437-
dc.description.citedreferenceMUTO T, 1975, CANCER, V36, P2251-
dc.description.citedreferenceKOZUKA S, 1975, DIS COLON RECTUM, V18, P494-
dc.description.tc16-
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Internal Medicine (내과학전공)Journal Papers (저널논문_내과학전공)
Files in This Item:
There are no files associated with this item.
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse